PremiumClass ActionLevi & Korsinsky LLP Notifies Shareholders of Viatris Inc.(VTRS) of a Class Action Lawsuit and an Upcoming Deadline Viatris put volume heavy and directionally bearish Concerns increase around adverse effects of benzodiazepines, WSJ says PremiumCompany AnnouncementsViatris Reports Strong 2024 Financial Results Viatris, Inc. Earnings Call: Balancing Growth and Challenges Viatris sees FY25 adjusted EPS $2.12-$2.26, consensus $2.59 PremiumThe FlyViatris announces publication of CARE study results Viatris Elects Directors and Amends Stock Plan at Meeting Viatris price target raised to $14 from $13 at Piper Sandler